Phase 2c Dose Comparison Study of MP4OX in Trauma

NCT01973504 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sangart ceased operations

Conditions

Trauma
Hemorrhagic Shock
Lactic Acidosis

Interventions

DRUG: MP4OX
DRUG: Control

Sponsor

Sangart